| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 12,750 | 15,942 | 19,243 | 18,120 | | Cost of Revenue | 5,011 | 6,510 | 8,266 | 7,500 | | | Gross Profit | 7,739 | 9,432 | 10,977 | 10,620 | | | Operating Expenses | | Research Development | 3,100 | 3,104 | 3,522 | 3,307 | | Selling General and Administrative | 5,722 | 5,986 | 6,422 | 6,418 | | Non Recurring |
-
|
-
| 17,090 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,083) | 342 | (16,057) | 895 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 126 | 251 | (88) | 138 | | Earnings Before Interest And Taxes | (957) | 593 | (16,145) | 1,033 | | Interest Expense | 28 | 23 | 32 | 35 | | Income Before Tax | (985) | 570 | (16,177) | 998 | | Income Tax Expense | 30 | 325 | (832) | 468 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,015) | 245 | (15,345) | 530 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,015) | 245 | (15,345) | 530 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,015) | $245 | ($15,345) | $530 |
|
0.01% Nasdaq 
0.02%
Income Statement
